Abstract:Objective:To explore the regulation of group 2 innate lymphoid cells (ILC2) recruitment by interleukin-33 (IL-33) , to examine the effect of ILC2 on macrophages during peritoneal infection in sepsis and to further elucidate the immune regulatory mechanism of peritoneal infection.Methods:Forty healthy 6 to 8 week-old male C57BL/6 wild-type mice, twenty Il-33 -/- mice on a C57BL/6 background, and ten IL-33 receptor ST2 knockout (Il1rl1 -/-) mice were bred and housed in the SPF Medical Animal Center of Zhejiang University and the University of Pittsburgh, USA. Receipts of sham surgery were designated as controls and underwent identical surgical procedures were septic mice. IL-33 protein was administered to rmIL-33 group via an exogenous intraperitoneal injection and the changes of ILC2 and its intracellular cytokine levels in peritoneal lavage fluid were detected by flow cytometry. The effects of IL-9 and IL-13 secreted by ILC2 on phagocytic ability of macrophages were confirmed by in vitro experiments. Statistical analysis was performed with t-test or one-way ANOVA test. Results:Compared with ILC2 before/after IL-33 stimulation, the proportion of ILC2 in Lin-CD45 + cells of abdominal cavity increased [(9.90±0.80) vs. (18.43±0.46) ]and the proportion of ILC2 in abdominal cavity jumped after IL-33 stimulation and the difference was statistically significant ( P<0.001). The number of ILC2 in abdominal cavity was [(5 786.00±289.50) vs. (17 820.00±324.30) ]and the number of ILC2 spiked in abdominal cavity after IL-33 stimulation and the difference was statistically significant ( P<0.001). C57BL/6 wild-type mice had a marked increase of peritoneal ILC2 recruitment as compared with control group at 24 h postoperatively [(20.50±0.59) vs. (10.83±1.01) ]and the difference was statistically significant ( P=0.001). However, ILC2 in peritoneal cavity of Il-33 -/- and Il1rl1 -/- mice showed no change at 24 h postoperatively. Moreover, the proportion of ILC2 in Il-33 -/- mice were significantly increased after IL-33 stimulation compared to non-stimulation group (10.53±0.47 vs. 19.43±0.87, P<0.001) , so as in the CLP induced septic mice (10.13±0.57 vs. 21.37±0.86, P<0.001). The study of cytokine levels secreted by ILC2 recruited from abdominal cavity showed that the levels of IL-9 and IL-13 secreted by ILC2 in abdominal cavity increased markedly at 12 h postoperatively and the contents of IL-9 before/after operation were [(16.53±0.74) vs. (24.67±1.45) ]and the differences were statistically significant ( P= 0.007). The proportions of IL-13 at pre/post-operation were [(15.40±0.87) vs. (29.40±0.95) ]and the differences were statistically significant ( P<0.001) while the contents of IL-4 were [(6.14±0.59) vs. (5.89±1.05) ]and the differences were not statistically significant ( P=0.836). An intraperitoneal injection of recombinant IL-33 protein promoted the recruitment of CD45 +F4/80 + macrophages in peritoneal cavity and the proportions before/after injection were [(52.40±1.70) vs. (72.40±2.02) ]and the difference was statistically significant ( P=0.002). Under the action of IL-9/13 secreted by ILC2, phagocytic ability of macrophages was markedly elevated as compared with control group. Phagocytic ability of macrophages under the action of IL-9 was [(61.27±1.46) vs. (48.30±1.65) ]and phagocytic ability of macrophages under the action of IL-13 was [(61.63±2.03) vs. (48.30±1.65) ]and the difference was statistically significant ( P=0.007). Conclusions:IL-33 promotes ILC2 and macrophage recruitment during peritoneal sepsis. And the recruitment of peritoneal ILC2 depends on IL-33/ST2 signaling pathway. Peritoneal ILC2 derived cytokines IL-9 and IL-13 enhance the phagocytosis of macrophages.

IL-33 Attenuates Sepsis by Inhibiting IL-17 Receptor Signaling through Upregulation of SOCS3.

Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.

Effect of Interleukin-36β on Activating Autophagy of CD4+CD25+ Regulatory T Cells and Its Immune Regulation in Sepsis.

Interleukin‐38 protects against sepsis by augmenting immunosuppressive activity of CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells

Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4+ CD25+ regulatory T cells.

Protective Role of Ilc2 in Sepsis-Induced Acute Lung Injury

Inhibition of Interleukin-3 Reversed the Inflammatory Response and Organ Damage Induced by Sepsis

The Immunoprotective Activity of Interleukin-33 in Mouse Model of Cecal Ligation and Puncture-Induced Sepsis.

Effect of interleukin-33 on apoptosis of T lymphocytes in a mouse model of sepsis

Autocrine Regulation of Interleukin-3 in the Activity of Regulatory T Cells and Its Effectiveness in the Pathophysiology of Sepsis

Interleukin-33 contributes to ILC2 activation and early inflammation-associated lung injury during abdominal sepsis.

Interleukin 35 contributes to immunosuppression by regulating inflammatory cytokines and T cell populations in the acute phase of sepsis

IL-27 Controls Sepsis-Induced Impairment of Lung Antibacterial Host Defence.

Complement C5a Regulates IL‐17 by Affecting the Crosstalk Between DC and Γδ T Cells in CLP‐induced Sepsis

Increased Susceptibility of S1PR3-Deficient Mice to Escherichia Coli Sepsis is Associated with an Impaired Bactericidal Activity in Macrophage

Interleukin-35 downregulates the immune response of effector cd4<sup>+</sup> t cells via restricting high mobility group box-1 protein-dependent autophagy in sepsis

Pathophysiology of sepsis: a focus on the activity of interleukin 33 (IL-33)

IL-33 regulated group 2 innate lymphoid cells promoted the phagocytosis of peritoneal macrophages during sepsis

Methylation of miR‐19b‐3p promoter exacerbates inflammatory responses in sepsis‐induced ALI via targeting KLF7

The inhibitor of interleukin-3 receptor protects against sepsis in a rat model of cecal ligation and puncture.

The growing spectrum of anti-inflammatory interleukins and their potential roles in the development of sepsis.